Australian Study Shows Treatment Advances for Peritoneal Mesothelioma
Australian Study Shows Treatment Advances for Peritoneal Mesothelioma Patients with peritoneal Australian Study Shows mesothelioma undergoing second cytoreductive surgery had median survival 92 Australia. That same group patients also had survival rate 71. ovarian,225 patients, from 1996 2018. Peritoneal metastasis, was in all the in the study, CRS/PIC surgery and perioperative intraperitoneal are becoming the standard care. Pleural mesothelioma risk may level off over several decades, but the risk for peritoneal mesothelioma never goes down. That is the conclusion of researchers at Italy’s University of Eastern Piedmont. It is based on data from more than 50,000 asbestos-exposed Italian workers. More than 40 years after asbestos exposure, the workers’ risk for peritoneal mesothelioma continued to rise. Asbestos is the primary cause of all types of malignant mesothelioma. Even peritoneal mesothelioma short-term asbestos exposure raises the risk for peritoneal meso...